38879-46-8

Basic information

• Product Name: (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one
• Synonyms: (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one;(4Z)-4-benzylidene-2-methyl-1,3-oxazol-5-one;(Z)-4-Benzylidene-2-methyloxazol-5(4H)-one;4-benzylidene-2-methyl-1,3-oxazol-5(4H)-one
• CAS NO: 38879-46-8
• Molecular Formula: C₁₁H₉NO₂
• Molecular Weight: 187.2
• Mol File: 38879-46-8.mol
• Article Data: 42

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one(38879-46-8)
• EPA Substance Registry System: (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one(38879-46-8)

Safety Data

• Hazardous Substances Data: 38879-46-8(Hazardous Substances Data)

Usage

General Description

(4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one is a chemical compound with the molecular formula C11H11NO2. It is a heterocyclic compound containing an oxazole ring and a phenyl group. (4Z)-2-Methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one has a molecular structure in which a ketone group is attached to the oxazole ring, and a phenyl group is attached to the carbon at position 4 of the oxazole ring. It is a yellow to orange solid in its pure form and is used in the synthesis of various pharmaceuticals and agrochemicals. It has potential applications in the research and development of new drugs due to its various chemical and biological properties.

Upstream product

• 108-24-7 acetic anhydride 
• 100-52-7 benzaldehyde 
• 543-24-8 N-acetylglycine 
• 2901-75-9 (R,S)-N-acetyl phenylalanine 
• 1906-82-7 ethyl acetamidoacetate 
• 98-01-1 furfural 
• 143417-47-4 (4E)-2-methyl-4-(phenylmethylidene)-4,5-dihydro-1,3-oxazol-5-one 
• 495-69-2 Hippuric Acid 
• 75-07-0 acetaldehyde 
• 5356-71-8 1,3-diphenyl-1H-pyrazol-5-amine 
• 24474-93-9 2-methyl-4H-oxazol-5-one 
• 538-51-2 benzylidene phenylamine 
• 56-40-6 glycine 
• 55065-02-6 2-(N-acetylamino)cinnamic acid 

Downstream Products

• 138190-33-7 4-benzylidene-2-methyl-4H-thiazol-5-one 
• 101602-73-7 N-acetyl dehydrophenylalanine cyclohexylamide 
• 49659-69-0 4-benzylidene-2-styryloxazolin-5-one 
• 102592-54-1 N-[1-(α-hydroxy-benzhydryl)-2-phenyl-vinyl]-acetamide 
• 96462-17-8 4-(α-acetoxy-α-chloro-benzyl)-4-chloro-2-trichloromethyl-4H-oxazol-5-one 
• 77008-44-7 α-acetamidocinnamanilide 
• 55636-11-8 α-acetylamino-trans-cinnamic acid benzylamide 
• 99866-39-4 4-((Z)-benzylidene)-2-dibromomethyl-4H-oxazol-5-one 
• 99866-61-2 4-benzylidene-2-dichloromethyl-4H-oxazol-5-one 
• 1738-50-7 α-(5-methyl-tetrazol-1-yl)-trans-cinnamic acid 
• 2901-75-9 (R,S)-N-acetyl phenylalanine 
• 93341-45-8 α-acetylamino-4-nitro-trans-cinnamic acid 
• 112048-51-8 β-chloro-α-(2-chloro-acetylamino)-cinnamic acid 
• 97066-46-1 2-Brom-1-dibromacetylamino-zimtsaeure 

Relevant articles and documents

A photoinduced refractive index increase in poly(methyl methacrylate) film doped with N-acetyl-α-dehydroarylalanine naphthyl esters

The short period of time irradiation of poly(methyl) methacrylate) (PMMA) film doped with N-acetyl-α-dehydrophenylalanine 1-naphthyl ester (1a) or N-acetyl-α-dehydro(1-naphthyl)alanine 1-naphthyl ester (1b) that increases the refractive index of the polym

Concise synthesis and applications of enantiopure spirobiphenoxasilin-diol and its related chiral ligands

The development of chiral architectures for chiral ligand and catalyst discovery is essential for asymmetric catalysis. Herein, we report the concise synthesis of a Si-centered spirocyclic skeleton, spirobiphenoxasilin-diol (SPOSiOL), and its derived chiral ligands. Using the chemical resolution method, the optical SPOSiOL could be obtained in high yield on a gram scale. Preliminary studies indicated that this ligand scaffold has great potential in transition metal-catalyzed asymmetric reactions. This finding further highlights that the Si-centered spirocyclic scaffolds are of great value in asymmetric catalysis. This journal is

Pharmaceutical composition and method of treating cancer

Cytotoxic compounds containing a phenyl core, amide link(s), an imidazolinone or a propenamide moiety. Also described are pharmaceutical compositions incorporating the cytotoxic compounds and methods for treating cancer. These compounds are cytotoxic against breast, prostate, and leukemia cancer cell lines via dual inhibition of Src kinases and tubulin.